These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 30238771)
1. Indomethacin increases severity of Clostridium difficile infection in mouse model. Muñoz-Miralles J; Trindade BC; Castro-Córdova P; Bergin IL; Kirk LA; Gil F; Aronoff DM; Paredes-Sabja D Future Microbiol; 2018 Sep; 13(11):1271-1281. PubMed ID: 30238771 [TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM mBio; 2019 Jan; 10(1):. PubMed ID: 30622186 [No Abstract] [Full Text] [Related]
3. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection. Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769 [TBL] [Abstract][Full Text] [Related]
4. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis. Wang L; Cao J; Li C; Zhang L J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433 [TBL] [Abstract][Full Text] [Related]
5. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection. Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K mBio; 2020 May; 11(3):. PubMed ID: 32371595 [No Abstract] [Full Text] [Related]
6. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence. Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467 [TBL] [Abstract][Full Text] [Related]
7. Mouse relapse model of Clostridium difficile infection. Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341 [TBL] [Abstract][Full Text] [Related]
8. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection. Cribas ES; Denny JE; Maslanka JR; Abt MC Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048 [TBL] [Abstract][Full Text] [Related]
9. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis. Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Chicken IgY Specific to Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119 [No Abstract] [Full Text] [Related]
11. Antimicrobial Activity of Tannic Acid Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806 [TBL] [Abstract][Full Text] [Related]